GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers
Dong Li(Children's Hospital of Philadelphia), Marni J. Falk(Children's Hospital of Philadelphia), Ulrike B. S. Hedrich(Hertie Institute for Clinical Brain Research), Elias Aizenman(University of Pittsburgh), Konstanze Hörtnagel(CeGaT (Germany)), Stephen F. Traynelis(Emory University), Elizabeth M. McCormick(Children's Hospital of Philadelphia), Eric D. Marsh(Children's Hospital of Philadelphia), Hirofumi Kusumoto(Emory University), Johannes R. Lemke(Leipzig University), Xilma R. Ortiz‐González(Children's Hospital of Philadelphia), Claudia Naase(Bayreuth Medical Center), Gabrielle J. Kosobucki(University of Pittsburgh), Celina von Stülpnagel-Steinbeis(Paracelsus Medical University), Gina E. Elsen(Hertie Institute for Clinical Brain Research), Rosetta Chiavacci(Children's Hospital of Philadelphia), Lifeng Tian(Children's Hospital of Philadelphia), Anthony J. Schulien(University of Pittsburgh), Håkon Håkonarson(Children's Hospital of Philadelphia), Hongjie Yuan(Emory University), Wenjuan Chen(First Affiliated Hospital of Henan University of Science and Technology), Anel Tankovic(Emory University), Chun Hu(Emory University), F Brueckner(Hamburg Institute for Social Research)
Cited by 183
Related Papers
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|776
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
|Pharmacological Reviews|2021|676
Control of GluR1 AMPA Receptor Function by cAMP-Dependent Protein Kinase
|Journal of Neuroscience|2000|646
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
|Genetics in Medicine|2014|605